Clinical significance of serum autoantibodies in patients with sarcoidosis

References

• Korsten P, Tampe B, Konig MF, et al. Sarcoidosis and autoimmune diseases: differences, similarities and overlaps. Curr Opin Pulm Med. 2018;24(5):504–512.
   PubMed Web of Science ®Google Scholar
• Ramos-Casals M, Brito-Zerón P, García-Carrasco M, et al. Sarcoidosis or sjogren syndrome? Clues to defining mimicry or coexistence in 59 cases. Medicine (Baltimore. 2004;83(2):85–95.
   PubMed Web of Science ®Google Scholar
• Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362(9388):971–982.
   PubMed Web of Science ®Google Scholar
• Nakamura H, Genma R, Mikami T, et al. High incidence of positive autoantibodies against thyroid peroxidase and thyroglobulin in patients with sarcoidosis. Clin Endocrinol (Oxf). 1997;46(4):467–472.
   PubMed Web of Science ®Google Scholar
• Cozzi D, Bargagli E, Calabrò AG, et al. Atypical HRCT manifestations of pulmonary sarcoidosis. Radiol Med. 2018;123(3):174–184.
   PubMed Web of Science ®Google Scholar
• Fischer A, Antoniou KM, Brown KK, et al. An official european respiratory society/American thoracic society research statement: interstitial pneumonia with autoimmune features. Eur Respir J. 2015;46(4):976–987.
   PubMed Web of Science ®Google Scholar
• Chapman CJ, Murray A, McElveen JE, et al. Autoantibodies in lung cancer: possibleties for early detection and subsequent cure. Thorax. 2008;63(3):228–233.
   PubMed Web of Science ®Google Scholar
• Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160(2):736–755.
   PubMedGoogle Scholar
• Satoh M, Ceribelli A, Hirakata M, et al. Immunodiagnosis of autoimmune myopathies; 2016. 8th ed. Detrick B, Schmitz JL, Hamilton RG, editors. Manual of molecular and clinical laboratory immunology. Washington (DC): American Society of Microbiology Press 2016. p. 878–887.
   Google Scholar
• Duan J, Xu Y, Zhu H, et al. Relationship between CT activity score with lung function and the serum angiotensin converting enzyme in pulmonary sarcoidosis on chest HRCT. Medicine (Baltimore). 2018;97(36):e12205.
   PubMed Web of Science ®Google Scholar
• Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years’ observation. Br Med J. 1961;2(5261):1165–1172.
   PubMed Web of Science ®Google Scholar
• Akira M, Kozuka T, Inoue Y, et al. Long-term follow-up CT scan evaluation in patients with pulmonary sarcoidosis. Chest. 2005;127(1):185–191.
   PubMed Web of Science ®Google Scholar
• Swigris JJ, Olson AL, Huie TJ, et al. Sarcoidosis-related mortality in the United States from 1988 to 2007. Am J Respir Crit Care Med. 2011;183(11):1524–1530.
   PubMed Web of Science ®Google Scholar
• Kirkil G, Lower EE, Baughman RP. Predictors of mortality in pulmonary sarcoidosis. Chest. 2018;153(1):105–113.
   PubMed Web of Science ®Google Scholar
• Correia CS, Briones MR, Guo R, et al. Elevated anti-cyclic citrullinated peptide antibody titer is associated with increased risk for interstitial lung disease. Clin Rheumatol. 2019;38(4):1201–1206.
   PubMed Web of Science ®Google Scholar
• Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86(4):1343–1346.
   PubMed Web of Science ®Google Scholar
• Song GG, Bae SC, Kim JH, et al. The angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to rheumatoid arthritis, vitiligo and psoriasis: a meta-analysis. J Renin Angiotensin Aldosterone Syst. 2015;16(1):195–202.
   PubMed Web of Science ®Google Scholar
• Brincker H. Sarcoid reactions in malignant tumours. Cancer Treat Rev. 1986;13(3):147–156.
   PubMed Web of Science ®Google Scholar
• Weinberg I, Vasiliev L, Gotsman I. Anti-dsDNA antibodies in sarcoidosis. Semin Arthritis Rheum. 2000;29(5):328–331.
   PubMed Web of Science ®Google Scholar
• Svendsen CB, Milman N, Høier-Madsen M, et al. Determination of rickettsial and antinuclear antibodies in danish patients with sarcoidosis. Clin Respir J. 2008;2(4):202–207.
   PubMed Web of Science ®Google Scholar
• Kobak S, Yilmaz H, Sever F, et al. The prevalence of antinuclear antibodies in patients with sarcoidosis. Autoimmune Dis. 2014;2014:351852.
   PubMedGoogle Scholar
• Kunkel HG, Simon HJ, Fudenberg H. Observations concerning positive serologic reactions for rheumatoid factor in certain patients with sarcoidosis and other hyperglobulinemic states. Arthritis Rheum. 1958;1(4):289–296.
   PubMedGoogle Scholar
• Oreskes I, Siltzbach LE. Changes in rheumatoid factor activity during the course of sarcoidosis. Am J Med. 1968;44(1):60–67.
   PubMed Web of Science ®Google Scholar
• Ueda-Hayakawa I, Nguyen CTH, Kishimoto I, et al. Clinical characteristics of sarcoidosis patients with systemic sclerosis-specific autoantibody: possible involvement of thymus and activation-regulated chemokine and a review of the published works. J Dermatol. 2019;46(7):577–583.
   PubMed Web of Science ®Google Scholar
• Kobak S, Ylmaz H, Sever F, et al. Anti-cyclic citrullinated peptide antibodies in patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31(3):206–210.
   PubMed Web of Science ®Google Scholar
• Meliconi R, Bestagno M, Sturani C, et al. Autoantibodies to DNA topoisomerase II in cryptogenic fibrosing alveolitis and connective tissue disease. Clin Exp Immunol. 1989;76(2):184–189.
   PubMed Web of Science ®Google Scholar
• Negri C, Scovassi AI, Cerino A, et al. Autoantibodies to poly(ADP-ribose)polymerase in autoimmune diseases. Autoimmunity. 1990;6(3):203–209.
   PubMed Web of Science ®Google Scholar
• Erlinger R, Rauh G, Behr J, et al. Similar frequency of autoantibodies against pneumocytes type II and clara cells in patients with interstitial lung diseases and healthy persons. Klin Wochenschr. 1991;69(7):297–302.
   PubMedGoogle Scholar
• Ina Y, Takada K, Yamamoto M, et al. Antiphospholipid antibodies. A prognostic factor in sarcoidosis? Chest. 1994;105(4):1179–1183.
   PubMed Web of Science ®Google Scholar
• Forde AM, Feighery C, Jackson J. Anti-monocyte cytoplasmic antibodies in granulomatous disease. Clin Immunol Immunopathol. 1996;81(1):88–95.
   PubMedGoogle Scholar
• Papadopoulos KI, Hornblad Y, Liljebladh H, et al. High frequency of endocrine autoimmunity in patients with sarcoidosis. Eur J Endocrinol. 1996;134(3):331–336.
   PubMed Web of Science ®Google Scholar
• Dong X, Wang J, Kabir FN, et al. Autoantibodies to DEK oncoprotein in human inflammatory disease. Arthritis Rheum. 2000;43(1):85–93.
   PubMedGoogle Scholar
• Inui N, Matsui T, Suda T, et al. Anti-endothelial cell antibodies in patients with sarcoidosis. Chest. 2008;133(4):955–960.
   PubMed Web of Science ®Google Scholar
• Kinloch AJ, Kaiser Y, Wolfgeher D, et al. In situ humoral immunity to vimentin in HLA-DRB1*03(+) patients with pulmonary sarcoidosis. Front Immunol. 2018;9:1516.
   PubMed Web of Science ®Google Scholar
• Attali JR, Valensi P, Valeyre D, et al. Thyroid stimulating antibodies in sarcoidosis. Pathol Biol (Paris). 1994;42(6):581–586.
   PubMedGoogle Scholar
• Ilias I, Panoutsopoulos G, Batsakis C, et al. Thyroid function and autoimmunity in sarcoidosis: a case-control study. Croat Med J. 1998;39(4):404–406.
   PubMedGoogle Scholar
• Antonelli A, Fazzi P, Fallahi P, et al. Prevalence of hypothyroidism and graves disease in sarcoidosis. Chest. 2006;130(2):526–532.
   PubMed Web of Science ®Google Scholar
• Malli F, Bargiota A, Theodoridou K, et al. Increased primary autoimmune thyroid diseases and thyroid antibodies in sarcoidosis: evidence for an under-recognised extrathoracic involvement in sarcoidosis? Hormones (Athens). 2012;11(4):436–443.
   PubMedGoogle Scholar